KEVIN STARR

Profile

First Name

: KEVIN

Middle Name

:

Last Name

: STARR

Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER, DIRECTOR
AFFERENT PHARMACEUTICALS, INC.
MITCHELL S. BLOOM, ANTHONY FORD, KATHLEEN SEREDA GLAUB, PETER HIRTH, MICHAEL KITT, DAVID NEAFUS, ARTHUR PAPPAS, LIAM RATCLIFFE, JESSE TREU
DIRECTOR
ZAFGEN, INC.
PETER BARRETT, CAROLE BEN MAIMON, MD, MITCHELL BLOOM, MITCHELL S. BLOOM, BRUCE BOOTH, MICHAEL CELANO, THOMAS O. DANIEL, ARI GOLDBERG, AVI GOLDBERG, THOMAS HAMILTON, FRANCES HELLER, THOMAS HUGHES, MATTHIAS JAFFE, DENNIS D. KIM, JONATHAN LEFF, DR. LIAM RATCLIFFE, LOU TARTAGLIA, LOUIS TARTAGLIA, FRANK E. THOMAS, JOSEPH TRUITT
DIRECTOR
AGIOS PHARMACEUTICALS INC
LEWIS C. CANTLEY, DOUG COLE, DUNCAN HIGGONS, PERRY KARSEN, JOHN MARAGANORE, ROBERT NELSEN, DAVID SCHENKEIN, MARC TESSIER-LAVIGNE
DIRECTOR
PANOPTICA, INC.
ABBIE CELNIKER, PAUL CHANEY, THOMAS DYRBERG, LUTZ GIEBEL, COLIN GODDARD, DAVID GUYER, GIEBEL LUTZ, BRUCE PEACOCK, TRACY SAXTON
DIRECTOR
MYOKARDIA INC
KATHERINE BOWDISH, TASSOS ANASTASIOS GIANAKAKOS, CHARLES HOMCY, MARK PERRY
EXECUTIVE OFFICER
THIRD ROCK VENTURES III, L.P.
MARK LEVIN, ROBERT TEPPER, N/A THIRD ROCK VENTURES GP III, L.P., N/A TRV GP III, LLC
DIRECTOR
SAGE THERAPEUTICS, INC.
ELIZABETH BARRETT, MICHAEL CLOONAN, MICHAEL F. COLA, ANNE MARIE COOK, JAMES F. FRATES, GENO GERMANO, GEORGE GOLUMBESKI, BARRY GREENE, KIMI IGUCHI, JEFFERY M. JONAS, JEFFREY M. JONAS, STEPHEN J. KANES, ROBERT T. NELSEN, STEVEN PAUL, ALBERT J. ROBICHAUD, KEVIN P. STARR
DIRECTOR
GLOBAL BLOOD THERAPEUTICS, INC.
CHARLES HOMCY, M.D., TED W. LOVE, JOHN SCHEMBRI
EXECUTIVE OFFICER, DIRECTOR
DECIBEL THERAPEUTICS, INC.
TROY BRENNAN, ROGER BROWN, JENS ECKSTEIN, NEIL EXTER, STEVEN H. HOLTZMAN, JEFFREY JONAS, JOHN J. KEILTY, ELISABETH LEIDERMAN, CRAIG MUIR, ANTHONY PHILIPPAKIS, CHRISTINE A. POON, LAURENCE REID, GEORGE SCANGOS, MICHAEL SOLOMON, PETER A. THOMPSON
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2017-10-16
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-04-10 
2017-01-13
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-10-13 
2016-05-27
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-04-10 
2015-10-27
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-10-13 
2015-07-14
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-07-01 
2015-04-30
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-04-20 
2015-01-05
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2014-12-22 
2014-08-22
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-08-01 
2014-04-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-04-10 
2014-03-24
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2014-03-11 
2014-01-21
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2014-01-07 
2013-03-25
D
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
 
2013-03-15 
2012-12-05
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2012-11-30 
2012-10-03
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-09-11 
2012-10-03
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-08-09 
2012-08-28
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Debt 
2012-08-13 
2012-03-06
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-12-10 
2011-11-22
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2011-11-16 
2011-07-12
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2011-06-30 
2010-12-27
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-12-10 
2010-04-26
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2010-04-14 
2010-03-02
D/A
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2010-02-17 
2010-03-01
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2010-02-17 
2009-12-18
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2009-12-09 
2009-11-05
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
 
2009-10-23